However, perhaps the main question is the relative importance of NLR in the different BC subtypes: in the early BC setting, one metanalysis showed that the prognostic value of NLR was clear for HER2+ and TNBC disease, while no differences were apparent in luminal A and B breast cancer23. Here, ERBB2 is linked to breast cancer.